This multi-domain framework estimates pre-disease risk using non-invasive proxies, suggesting a new approach to risk stratification.
This work presents a system-level framework for estimating pre-disease risk using non-invasive proxy variables. The model integrates behavioral, physiological, and structural signals into a composite risk engine and is validated through a synthetic cohort designed to reflect realistic correlation structures. Unlike traditional diagnostic approaches, this framework focuses on pre-disease risk accumulation and introduces a scalable method for risk stratification, attribution, and counterfactual simulation. The system is positioned as a pre-disease risk pricing layer applicable to public health screening, clinical trial stratification, and insurance underwriting.
No takes yet. Share an insight, caveat, or question.
Yao Hui Huang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: